Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fluconazole 150mg capsules
0502010B0AAABAB
|
Fluconazole | Fluconazole | Infections | 71,328 |
|
Fluconazole 50mg capsules
0502010B0AAAAAA
|
Fluconazole | Fluconazole | Infections | 51,115 |
|
Fluconazole 50mg/5ml oral suspension
0502010B0AAAGAG
|
Fluconazole | Fluconazole | Infections | 3,338 |
|
Fluconazole 200mg capsules
0502010B0AAACAC
|
Fluconazole | Fluconazole | Infections | 3,144 |
|
Fluconazole 200mg/5ml oral suspension
0502010B0AAAHAH
|
Fluconazole | Fluconazole | Infections | 262 |
|
Fluconazole 200mg/100ml solution for infusion vials
0502010B0AAAEAE
|
Fluconazole | Fluconazole | Infections | 4 |
|
Fluconazole 200mg/100ml solution for infusion bottles
0502010B0AAALAL
|
Fluconazole | Fluconazole | Infections | 1 |
|
Fluconazole 50mg/25ml solution for infusion vials
0502010B0AAADAD
|
Fluconazole | Fluconazole | Infections | 1 |
|
Fluconazole 100mg/50ml solution for infusion bottles
0502010B0AAAMAM
|
Fluconazole | Fluconazole | Infections | No data available |
|
Fluconazole 100mg/50ml solution for infusion vials
0502010B0AAAPAP
|
Fluconazole | Fluconazole | Infections | No data available |
|
Fluconazole 200mg/100ml infusion bags
0502010B0AAAKAK
|
Fluconazole | Fluconazole | Infections | No data available |
|
Fluconazole 400mg/200ml infusion bags
0502010B0AAANAN
|
Fluconazole | Fluconazole | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.